Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company today announced having signed a license agreement for SunRock Biopharma’s SRB21, an HER3/HER2 antibody. SunRock Biopharma is a Galician company supported by the regional government, Xunta de Galicia, through Xesgalicia, devoted to the development of antibodies against highly invasive tumors with an urgent clinical need in oncology. Debiopharm has exercised its option to license SunRock Biopharma's bispeci...

Ralph Lauren (NYSE: RL) announces today that it will open a new restaurant as part of its renowned hospitality portfolio, The Polo Bar Ralph Lauren in London. The restaurant will be located at 1 Hanover Square and is set to open in 2028. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930206173/en/The Polo Bar Ralph Lauren Building on the international acclaim of The Polo Bar, which opened in New York in 2015 and quickly became a ...

Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the Netherlands-based Single Cell Discoveries as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, Single Cell Discoveries will expand access to Parse’s single cell technology, pairing it with a team uniquely dedicated to single cell science to support researchers across Europe and worldwide. Introduced in 2024, the CSP Program connects researchers w...

With less than 100 days to go until the Olympic Winter Games Milano Cortina 2026, new data from Visa Consulting & Analytics (VCA) finds a surge in flight bookings and ticket purchases for the Winter Games made with Visa across Italy’s host regions. By the numbers Ahead of the 2026 Winter Games, Northern Italy is expected to see a 160%+ increase in international travelers arriving by plane compared to this same time last winter. The largest contributors are flying in from the U.S., the ...

Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, today released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the operational frameworks needed to support these complex studies at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030722919/en/ The analysis shows that global therapeutic radiopharmaceutical trials have grown from just a...

With over 5.8 billion IoT cellular connections expected globally by 2030 (GSMA Intelligence) — powering everything from smart meters to wearable health trackers — the need for secure, scalable, and easy-to-manage connectivity is greater than ever. AT&T, a leader in connectivity and IoT solutions, and Thales, a global leader in advanced Cyber & Digital technologies, announce the launch of a new eSIM solution designed to help businesses remotely activate and manage IoT devices. This eSIM ...